ICU Medical, Inc.
ICUI
$133.31
$2.001.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 530.23M | 540.70M | 536.99M | 548.87M | 604.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 530.23M | 540.70M | 536.99M | 548.87M | 604.70M |
| Cost of Revenue | 324.00M | 337.72M | 336.11M | 340.80M | 394.59M |
| Gross Profit | 206.23M | 202.99M | 200.88M | 208.06M | 210.11M |
| SG&A Expenses | 154.57M | 155.81M | 152.77M | 159.39M | 157.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 499.85M | 514.62M | 510.13M | 522.06M | 575.12M |
| Operating Income | 30.38M | 26.09M | 26.86M | 26.81M | 29.59M |
| Income Before Tax | -4.58M | -18.39M | -4.05M | 36.52M | -10.91M |
| Income Tax Expenses | -34.71M | -2.65M | -658.00K | 1.18M | 4.57M |
| Earnings from Continuing Operations | 30.13M | -15.73M | -3.40M | 35.34M | -15.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.13M | -15.73M | -3.40M | 35.34M | -15.48M |
| EBIT | 30.38M | 26.09M | 26.86M | 26.81M | 29.59M |
| EBITDA | 80.41M | 76.92M | 77.66M | 76.47M | 79.03M |
| EPS Basic | 1.22 | -0.64 | -0.14 | 1.43 | -0.63 |
| Normalized Basic EPS | 0.31 | 0.12 | 0.19 | 0.28 | 0.15 |
| EPS Diluted | 1.20 | -0.64 | -0.14 | 1.43 | -0.63 |
| Normalized Diluted EPS | 0.31 | 0.12 | 0.19 | 0.28 | 0.15 |
| Average Basic Shares Outstanding | 24.76M | 24.69M | 24.69M | 24.65M | 24.54M |
| Average Diluted Shares Outstanding | 25.18M | 24.69M | 24.69M | 24.71M | 24.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |